Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC)

Historical Holders from Q2 2015 to Q3 2025

Symbol
TDOC on NYSE
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
176M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
123M
Holdings value
$953M
% of all portfolios
0.002%
Grand Portfolio weight change
0%
Number of holders
341
Number of buys
164
Number of sells
-154
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 11.98% $183M 21M The Vanguard Group 30 Jun 2025
BlackRock, Inc. 7.8% $99.4M 13.6M BlackRock, Inc. 31 Mar 2025
Point72 Asset Management, L.P. 3.3% -34% $44.8M -$23.4M 5.8M -34.3% Point72 Asset Management, L.P. 30 Sep 2025

Institutional Holders of Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 123M $953M -$44.1M $7.73 341
2025 Q2 128M $1.11B +$28.9M $8.71 348
2025 Q1 125M $993M -$13.2M $7.96 368
2024 Q4 127M $1.15B +$5.73M $9.09 366
2024 Q3 125M $1.15B -$101M $9.18 352
2024 Q2 139M $1.36B +$78.9M $9.78 389
2024 Q1 130M $1.96B +$8.56M $15.10 411
2023 Q4 128M $2.76B +$64.1M $21.55 425
2023 Q3 125M $2.32B -$112M $18.59 418
2023 Q2 129M $3.26B -$198M $25.32 418
2023 Q1 136M $3.53B +$69.7M $25.90 416
2022 Q4 135M $3.19B -$88.5M $23.65 419
2022 Q3 138M $3.5B -$133M $25.35 421
2022 Q2 143M $4.75B -$35.5M $33.21 492
2022 Q1 135M $9.76B -$44.2M $72.13 640
2021 Q4 136M $12.5B -$96.7M $91.82 689
2021 Q3 133M $16.9B +$674M $126.81 738
2021 Q2 128M $21.3B +$1.04B $166.29 807
2021 Q1 121M $22B +$973M $181.75 873
2020 Q4 109M $21.8B +$6.58B $199.96 869
2020 Q3 75.6M $16.6B +$918M $219.24 730
2020 Q2 71.5M $13.6B -$181M $190.84 654
2020 Q1 72.8M $11.3B -$2.13B $155.01 559
2019 Q4 87M $7.29B -$311M $83.72 404
2019 Q3 90.9M $6.15B +$311M $67.72 365
2019 Q2 86.3M $5.71B +$184M $66.41 360
2019 Q1 85M $4.72B +$201M $55.60 355
2018 Q4 81.5M $4.04B +$65.5M $49.57 321
2018 Q3 78.7M $6.79B +$279M $86.35 330
2018 Q2 76M $4.41B -$62.8M $58.05 272
2018 Q1 77.2M $3.11B +$70.2M $40.30 229
2017 Q4 75.6M $2.64B +$301M $34.85 204
2017 Q3 65.3M $2.17B +$268M $33.15 177
2017 Q2 57.3M $1.99B +$289M $34.70 165
2017 Q1 50.8M $1.27B +$613M $25.00 131
2016 Q4 28.8M $476M +$62.3M $16.50 107
2016 Q3 24.6M $450M +$92.9M $18.31 101
2016 Q2 18.5M $296M +$63.3M $16.02 85
2016 Q1 15.8M $152M -$36.7M $9.60 78
2015 Q4 18.7M $335M -$60.4M $17.96 73
2015 Q3 20.9M $458M +$452M $22.29 88
2015 Q2 266K $5.01M +$5.01M $19.00 14